Cited2 is required for fetal lung maturation.

[1]  J. Martinez-Barbera,et al.  Adrenal development is initiated by Cited2 and Wt1 through modulation of Sf-1 dosage , 2007, Development.

[2]  W. Scherbaum,et al.  CITED2 is expressed in human adrenocortical cells and regulated by basic fibroblast growth factor. , 2007, The Journal of endocrinology.

[3]  L. Didon,et al.  Ectopic expression of C/EBPalpha in the lung epithelium disrupts late lung development. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[4]  Yifan Chen,et al.  Cited2 modulates TGF-β-mediated upregulation of MMP9 , 2006, Oncogene.

[5]  H. Li,et al.  AP-2α and AP-2γ are transcriptional targets of p53 in human breast carcinoma cells , 2006, Oncogene.

[6]  S. Dunwoodie,et al.  Loss of Cited2 affects trophoblast formation and vascularization of the mouse placenta. , 2006, Developmental biology.

[7]  J. Lü,et al.  Regulation of early lung morphogenesis: questions, facts and controversies , 2006, Development.

[8]  J. Whitsett,et al.  C/EBPα is required for lung maturation at birth , 2006 .

[9]  T. Golub,et al.  Respiratory Failure Due to Differentiation Arrest and Expansion of Alveolar Cells following Lung-Specific Loss of the Transcription Factor C/EBPα in Mice , 2006, Molecular and Cellular Biology.

[10]  J. Cleveland,et al.  Two transactivation mechanisms cooperate for the bulk of HIF‐1‐responsive gene expression , 2005, The EMBO journal.

[11]  S. Dunwoodie,et al.  Cited2 is required both for heart morphogenesis and establishment of the left-right axis in mouse development , 2005, Development.

[12]  Robert H. Anderson,et al.  Cited2 controls left-right patterning and heart development through a Nodal-Pitx2c pathway , 2004, Nature Genetics.

[13]  J. Whitsett,et al.  Genetic disorders influencing lung formation and function at birth. , 2004, Human molecular genetics.

[14]  M. Konishi,et al.  Fgf18 is required for embryonic lung alveolar development. , 2004, Biochemical and biophysical research communications.

[15]  J. W. Davis,et al.  Identification of the CREB-binding Protein/p300-interacting Protein CITED2 as a Peroxisome Proliferator-activated Receptor α Coregulator* , 2004, Journal of Biological Chemistry.

[16]  J. Whitsett,et al.  ABCA3 gene mutations in newborns with fatal surfactant deficiency. , 2004, The New England journal of medicine.

[17]  C. Speer,et al.  Impact of Basic Research on Tomorrow's MedicineThe Role of Transforming Growth Factor β in Lung Development and Disease , 2004 .

[18]  T. McDonnell,et al.  Transcriptional Regulation of bcl-2 Mediated by the Sonic Hedgehog Signaling Pathway through gli-1* , 2004, Journal of Biological Chemistry.

[19]  H. Sun,et al.  CITED2-mediated Regulation of MMP-1 and MMP-13 in Human Chondrocytes under Flow Shear* , 2003, Journal of Biological Chemistry.

[20]  M. Nord,et al.  C/EBP transcription factors in the lung epithelium. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[21]  Gerhard Wagner,et al.  Structural basis for negative regulation of hypoxia-inducible factor-1α by CITED2 , 2003, Nature Structural Biology.

[22]  V. Kaartinen,et al.  Growth factor signaling in lung morphogenetic centers: automaticity, stereotypy and symmetry , 2003, Respiratory research.

[23]  Helen C. Hurst,et al.  Physical and Functional Interactions among AP-2 Transcription Factors, p300/CREB-binding Protein, and CITED2* , 2003, The Journal of Biological Chemistry.

[24]  V. Boggaram Regulation of lung surfactant protein gene expression. , 2003, Frontiers in bioscience : a journal and virtual library.

[25]  K. Herrup,et al.  The essential role of Cited2, a negative regulator for HIF-1α, in heart development and neurulation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Mengshu Wang,et al.  Members of the C/EBP transcription factor family stimulate expression of the human and rat surfactant protein A (SP-A) genes. , 2002, Biochimica et biophysica acta.

[27]  A. Simeone,et al.  Folic acid prevents exencephaly in Cited2 deficient mice. , 2002, Human molecular genetics.

[28]  Jennifer N. Murdoch,et al.  Cardiac malformations, adrenal agenesis, neural crest defects and exencephaly in mice lacking Cited2, a new Tfap2 co-activator , 2001, Nature Genetics.

[29]  D. Ornitz,et al.  Lung hypoplasia and neonatal death in Fgf9-null mice identify this gene as an essential regulator of lung mesenchyme. , 2001, Development.

[30]  A. W. Murray,et al.  Alveolar type II cell apoptosis. , 2001, Comparative biochemistry and physiology. Part A, Molecular & integrative physiology.

[31]  R. Buettner,et al.  Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control. , 2000, Gene.

[32]  M. Lane,et al.  Sequential repression and activation of the CCAAT enhancer-binding protein-alpha (C/EBPalpha ) gene during adipogenesis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[33]  M. Rämet,et al.  Association between the surfactant protein A (SP-A) gene locus and respiratory-distress syndrome in the Finnish population. , 2000, American journal of human genetics.

[34]  R. Maurer,et al.  MRG1 Binds to the LIM Domain of Lhx2 and May Function as a Coactivator to Stimulate Glycoprotein Hormone α-Subunit Gene Expression* , 1999, The Journal of Biological Chemistry.

[35]  L. Muglia,et al.  Proliferation and differentiation defects during lung development in corticotropin-releasing hormone-deficient mice. , 1999, American journal of respiratory cell and molecular biology.

[36]  Yuh Cheng Yang,et al.  MRG1, the product of a melanocyte-specific gene related gene, is a cytokine-inducible transcription factor with transformation activity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[37]  D. Danilenko,et al.  Fgf-10 is required for both limb and lung development and exhibits striking functional similarity to Drosophila branchless. , 1998, Genes & development.

[38]  J. Crawley,et al.  Selectively enhanced contextual fear conditioning in mice lacking the transcriptional regulator CCAAT/enhancer binding protein delta. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[39]  J. Whitsett,et al.  VEGF enhances pulmonary vasculogenesis and disrupts lung morphogenesis in vivo , 1998, Developmental dynamics : an official publication of the American Association of Anatomists.

[40]  R. Beddington,et al.  Msg1 and Mrg1, founding members of a gene family, show distinct patterns of gene expression during mouse embryogenesis , 1998, Mechanisms of Development.

[41]  S. Akira,et al.  Defective adipocyte differentiation in mice lacking the C/EBPβ and/or C/EBPδ gene , 1997 .

[42]  Joseph L. Alcorn,et al.  Transcription Factor C/EBPδ in Fetal Lung: Developmental Regulation and Effects of Cyclic Adenosine 3',5'-Monophosphate and Glucocorticoids. , 1997, Endocrinology.

[43]  R. Weigel,et al.  Identification of ERF-1 as a member of the AP2 transcription factor family. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[44]  J. Whitsett,et al.  Expression of thyroid transcription factor-1(TTF-1) in fetal and neonatal human lung. , 1996, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[45]  P. Chambon,et al.  AP-2.2: a novel AP-2-related transcription factor induced by retinoic acid during differentiation of P19 embryonal carcinoma cells. , 1996, Experimental cell research.

[46]  J. Whitsett,et al.  Arrested lung morphogenesis in transgenic mice bearing an SP-C-TGF-beta 1 chimeric gene. , 1996, Developmental biology.

[47]  M. Melnick,et al.  The Glucocorticoid-Glucocorticoid Receptor Signal Transduction Pathway, Transforming Growth Factor-β, and Embryonic Mouse Lung Developmentin Vivo , 1996, Pediatric Research.

[48]  R. Schüle,et al.  Cloning and characterization of a second AP-2 transcription factor: AP-2 beta. , 1995, Development.

[49]  R. Cortese,et al.  Lymphoproliferative disorder and imbalanced T‐helper response in C/EBP beta‐deficient mice. , 1995, The EMBO journal.

[50]  J. Whitsett,et al.  Transforming growth factor-β inhibits surfactant protein A expression in vitro , 1992 .

[51]  R. Mason,et al.  Development of the type II cell in the fetal rat lung. , 1977, The American review of respiratory disease.

[52]  G. Semenza,et al.  Partial rescue of defects in Cited2-deficient embryos by HIF-1α heterozygosity , 2007 .

[53]  T. Weaver,et al.  Function of surfactant proteins B and C. , 2001, Annual review of physiology.

[54]  C. Mendelson,et al.  Role of transcription factors in fetal lung development and surfactant protein gene expression. , 2000, Annual review of physiology.

[55]  Nobuyuki Itoh,et al.  Fgf10 is essential for limb and lung formation , 1999, Nature Genetics.

[56]  S. Bhattacharya,et al.  Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1. , 1999, Genes & development.

[57]  J. Fallon,et al.  Fibroblast growth factors as multifunctional signaling factors. , 1999, International review of cytology.

[58]  P. Minoo,et al.  Epithelial-mesenchymal interactions in lung development. , 1994, Annual review of physiology.